Athenahealth Goes in Search of a Suitor

The transcript discusses a report from the New York Post about a bidding process for Athena, which is largely inaccurate. There are at least five bidders, both strategic and financial, with bids expected above $135 per share. Speculation surrounds Pamplona Capital and NThrive's involvement, though Athena has not engaged with them. Elliot, a significant shareholder, is expected to be part of the buyer group. The valuation is expected to be between $140 and $150 per share, with hopes of concluding the deal by the end of the month.

Who are the potential bidders mentioned in the report?

Evaluate responses using AI:

OFF

What is the current status of the bidding process for Athenahealth?

Evaluate responses using AI:

OFF

What role has Elliot played in the situation with Athenahealth?

Evaluate responses using AI:

OFF

What are the implications of a potential merger between Nthrive and Athenahealth?

Evaluate responses using AI:

OFF

What are the expected price ranges for Athenahealth's shares?

Evaluate responses using AI:

OFF